510(k) K231362
K231362 is an FDA 510(k) premarket notification submitted by TransMedics, Inc. for the device "OCS Heart Leukocyte Depleting Filter". The FDA issued a decision of Substantially Equivalent on October 31, 2023. The device falls under product code DTM (Filter, Blood, Cardiopulmonary Bypass, Arterial Line), a Class II device regulated under 21 CFR 870.4260. TransMedics, Inc. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 31, 2023
- Date Received
- May 11, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Filter, Blood, Cardiopulmonary Bypass, Arterial Line
- Device Class
- Class II
- Regulation Number
- 870.4260
- Review Panel
- CV
- Submission Type